Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Mani Inc. (7730:JPX), powered by AI.
Mani Inc. is currently trading at ¥1,682. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Mani Inc. on Alpha Lenz.
Mani Inc.'s P/E ratio is 35.7.
“Mani Inc. trades at a P/E of 35.7 (premium valuation) with solid ROE of 8.8%. 3Y revenue CAGR of 13.6% highlights clear growth momentum.”
Ask for details →Mani Inc. is a prominent player in the medical instruments industry, specializing in the manufacture and distribution of precision instruments and equipment crucial for surgical, dental, and ophthalmic procedures. The primary purpose of the company is to supply high-quality and reliable medical tools that enhance treatment efficacy and patient safety. Key features of Mani Inc.'s products include advanced manufacturing technologies, superior quality materials, and rigorous quality control processes that ensure optimal performance and durability. The company serves various sectors, including hospitals, clinics, dental practices, and ophthalmology centers, making it essential for the healthcare industry's operational framework. Mani Inc.'s influence extends across global markets, providing specialized medical devices essential for modern healthcare practices. This positions the company as a significant contributor to advancements in medical technology and patient care. Established with a commitment to precision and quality, Mani Inc. continues to support medical professionals worldwide with state-of-the-art tools and equipment, driving innovations in health and surgical techniques.
“Mani Inc. trades at a P/E of 35.7 (premium valuation) with solid ROE of 8.8%. 3Y revenue CAGR of 13.6% highlights clear growth momentum.”
Ask for details →Mani Inc. (ticker: 7730) is a company listed on JPX in the Healthcare sector (Medical Instruments & Supplies). It has approximately 4,154 employees. Market cap is $165.7B.
The current price is 1,682 with a P/E ratio of 35.68x and P/B of 3.09x.
ROE is 8.77% and operating margin is 27.34%. Annual revenue is $30.0B.